Novo Nordisk A/S

NVO · OMX

$39.05−$0.38 (−0.96%)TodayMarket closed · Oct 23, 7:59 PM ET

Prev close $39.43

Latest news

NewsOct 23, 2:24 PM ET
Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes
NewsOct 23, 7:01 AM ETTanya Rawat
More Americans Now Take GLP-1 Drugs for Weight Loss Than Diabetes as Food, Alcohol and Apparel Habits Shift, Survey Finds
NewsOct 20, 5:29 AM ETAkanksha Bakshi
Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research
NewsOct 8, 6:35 AM ETMohd Haider
Pharma Lobby Sues Trump Administration Over Medicare Drug Pricing Rule, Calls It ‘Unlawful Overreach’ — ‘The Results Are Preordained’
NewsOct 5, 11:47 AM ETVandana Singh
FDA Delays Regulatory Decision On Novo Nordisk Hemophilia Drug
NewsOct 3, 4:50 AM ETMohd Haider
Anthropic Commits $100 Million Behind AI Talent Push, Plans to Train 10,000 Engineers by 2027 as IPO Looms
NewsOct 2, 5:12 PM ET
Novo Provides Update On The Denecimig Biologics License Application In The US; The FDA Has Informed Novo That The BLA Review Of Denecimig For The Treatment Of Haemophilia A Is Still Ongoing; The FDA Has Not Communicated A New Timeline For Regulatory Action On The BLA
NewsOct 2, 1:19 PM ETVandana Singh
Regeneron Highlights Promising Ovarian Cancer, Muscle Preservation Trial Data
NewsOct 1, 2:50 PM ETVandana Singh
Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports
NewsSep 30, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 30, 1:14 PM ETVandana Singh
Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss
NewsSep 30, 10:29 AM ETVandana Singh
Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED)
NewsSep 29, 9:23 AM ETVandana Singh
Wegovy or Zepbound? Eli Lilly Shows Zepbound Outperforms Wegovy in New Weight Loss Data
NewsSep 28, 9:55 AM ETNamrata Sen
Anthropic Claude’s Claimed Breakthrough in Biology Faces a Major Question — Scientist Says He Had Already Studied the Enzymes for 4 Years
NewsSep 26, 1:30 PM ETMohd Haider
'We Don't Know What the Risks Are': GLP-1 Pill Boom Fuels Hundreds of Apps, but Research Is Lagging
NewsSep 25, 2:23 PM ETVandana Singh
What's Going on With Novo Nordisk Stock on Friday?
NewsSep 25, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 23, 4:54 PM ETErica Kollmann
QUICK SPARK: Viking Therapeutics Stock Gains 40% in 2 Days
NewsSep 23, 6:12 AM ETMohd Haider
Anthropic, OpenEvidence Expand Free AI Clinical Tool to 100 Countries: Report
NewsSep 22, 1:35 PM ET
3 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 22, 8:28 AM ETVandana Singh
Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures with Lilly, Pfizer
NewsSep 21, 12:04 PM ETAvi Kapoor
Crude Oil Down 4%; Intel Shares Move Higher
NewsSep 21, 9:13 AM ETVandana Singh
Beyond Ozempic: Novo Nordisk Plots Next Decade Growth with Bigger Pipeline, Slimmer Workforce
NewsSep 18, 4:12 PM ETChris Katje
Congressman Ditches Magnificent Seven Stocks for Consumer Staples: Here's What He Bought
NewsSep 17, 12:44 PM ETVandana Singh
EMA Committee Endorses Novo Nordisk's Hemophilia A Therapy
NewsSep 14, 6:57 AM ETNamrata Sen
Novo Nordisk Just Dropped ‘Nordisk’ From Its Name as Obesity Drug Battle With Eli Lilly Heats Up — Here’s Why
NewsSep 8, 8:30 AM ETVandana Singh
Wegovy for Overweight Young Children: Novo Nordisk’s Obesity Drug Shows Effectiveness
NewsAug 26, 2:17 PM ETVandana Singh
Boston Scientific Reports Global Disruption After Cybersecurity Incident
Press releaseAug 18, 12:57 PM ETGlobe Newswire
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
NewsAug 11, 11:27 AM ETPriya Nigam
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst
NewsAug 10, 12:03 PM ETVandana Singh
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule
NewsAug 6, 10:06 AM ETVandana Singh
Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray
NewsAug 6, 9:31 AM ETNamrata Sen
Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investment'
NewsJul 15, 2:39 PM ETVandana Singh
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug
Press releaseJul 9, 8:16 AM ETPRNewswire
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
Press releaseJul 7, 9:45 AM ETPRNewswire
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It
Press releaseMay 21, 9:00 AM ETGlobe Newswire
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
Press releaseMay 12, 10:30 AM ETPRNewswire
The $59B Quiet Shift Reshaping How Patients Access Care
NewsDec 20, 8:31 AM ET
Benzinga Bulls And Bears: Carnival, Caterpillar, Meta — And Markets Make Modest Gains
NewsNov 5, 12:40 PM ETAlex Perry
Novo Nordisk Q3 2025 Earnings Call Transcript
NewsOct 24, 5:01 PM ET
P/E Ratio Insights for Novo Nordisk
NewsOct 2, 2:49 PM ETAvi Kapoor
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
NewsSep 29, 8:06 AM ETAvi Kapoor
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsAug 19, 12:50 PM ETSurbhi Jain
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?
NewsJul 29, 8:20 AM ETAvi Kapoor
Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsApr 2, 8:57 AM ETVandana Singh
Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes

More Americans Now Take GLP-1 Drugs for Weight Loss Than Diabetes as Food, Alcohol and Apparel Habits Shift, Survey Finds

Oracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research

Pharma Lobby Sues Trump Administration Over Medicare Drug Pricing Rule, Calls It ‘Unlawful Overreach’ — ‘The Results Are Preordained’

FDA Delays Regulatory Decision On Novo Nordisk Hemophilia Drug

Anthropic Commits $100 Million Behind AI Talent Push, Plans to Train 10,000 Engineers by 2027 as IPO Looms

Novo Provides Update On The Denecimig Biologics License Application In The US; The FDA Has Informed Novo That The BLA Review Of Denecimig For The Treatment Of Haemophilia A Is Still Ongoing; The FDA Has Not Communicated A New Timeline For Regulatory Action On The BLA

Regeneron Highlights Promising Ovarian Cancer, Muscle Preservation Trial Data

Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

10 Health Care Stocks With Whale Alerts In Today’s Session

Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss

Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED)

Wegovy or Zepbound? Eli Lilly Shows Zepbound Outperforms Wegovy in New Weight Loss Data

Anthropic Claude’s Claimed Breakthrough in Biology Faces a Major Question — Scientist Says He Had Already Studied the Enzymes for 4 Years

'We Don't Know What the Risks Are': GLP-1 Pill Boom Fuels Hundreds of Apps, but Research Is Lagging

What's Going on With Novo Nordisk Stock on Friday?

10 Health Care Stocks With Whale Alerts In Today’s Session

QUICK SPARK: Viking Therapeutics Stock Gains 40% in 2 Days

Anthropic, OpenEvidence Expand Free AI Clinical Tool to 100 Countries: Report

3 Health Care Stocks With Whale Alerts In Today’s Session

Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures with Lilly, Pfizer

Crude Oil Down 4%; Intel Shares Move Higher

Beyond Ozempic: Novo Nordisk Plots Next Decade Growth with Bigger Pipeline, Slimmer Workforce

Congressman Ditches Magnificent Seven Stocks for Consumer Staples: Here's What He Bought

EMA Committee Endorses Novo Nordisk's Hemophilia A Therapy

Novo Nordisk Just Dropped ‘Nordisk’ From Its Name as Obesity Drug Battle With Eli Lilly Heats Up — Here’s Why

Wegovy for Overweight Young Children: Novo Nordisk’s Obesity Drug Shows Effectiveness

Boston Scientific Reports Global Disruption After Cybersecurity Incident

A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.

Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst

Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule

Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray

Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investment'

Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

The $59B Quiet Shift Reshaping How Patients Access Care

Benzinga Bulls And Bears: Carnival, Caterpillar, Meta — And Markets Make Modest Gains

Novo Nordisk Q3 2025 Earnings Call Transcript

P/E Ratio Insights for Novo Nordisk

This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?

Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales